Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Drug Development Services > Nonclinical > Bioanalytical > Overview
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
Bioanalytical Services
Overview
The Covance Approach
Strong scientific and regulatory knowledge combined with automation expertise, method development experts and experienced scientists who understand your need for timely and accurate communication allows Covance to offer extensive bioanalytical services from discovery through Phase IV.

The focus of bioanalysis is to provide a quantitative measure of the active drug and/or its metabolite(s). Samples may be derived from cell culture media or from other biological matrices (plasma, serum or urine etc). An appropriate bioanalytical technique is required to make these measurements. Selection of the correct technique may depend on the molecule's chemical nature, molecular weight, and structure.

Each of Covance's market-leading toxicology and clinical pharmacology (Phase I/IIa) units is complemented by a large, local bioanalytical unit, providing clients with the complete package of nonclinical requirements.

Bioanalytical Services
Our services can be applied throughout the drug development pathway. We offer:

Related Areas:
Antibody Services
Cardiac Safety Services
Central Laboratory Services
Clinical Pharmacology (Phase I-IIa)
Overview
Services
Systems & Technology
Resources & Expertise
News, Events & Publications
Contact